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Mutations in Succinate Dehydrogenase B (SDHB) enhance neutrophil survival 
independent of HIF-1alpha expression. 
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Neutrophils are unusual in their reliance on glycolysis to maintain their energy requirements
1
 
despite the presence of mitochondria and TCA cycle intermediaries
2
.  This metabolic 
adaptation is thought in part to underpin their survival and anti-microbial function in tissues 
that are typically hypoxic
3-5
.  Despite their unique metabolism, little is known about the 
importance of flux between metabolic pathways in determining neutrophil survival responses. 
Recent work has demonstrated the importance of the HIF/PHD oxygen-sensing pathway in 
this regard, identifying both HIF-1α and PHD3 as critical regulators of neutrophil survival in 
hypoxia
6,7
, with the extended survival of neutrophils in hypoxia being dependent upon HIF-1α   
expression. In parallel, an expanding body of work has addressed the role of HIF-1α in 
coordinating macrophage functional responses to pro-inflammatory mediators
8-11
.  This work 
led to the observation that, in macrophages, LPS causes an intracellular increase in succinate 
levels resulting in HIF-1α stabilization and enhanced IL-1β signaling
11
. Subsequently, the 
metabolic re-wiring of anti-microbial (M1) and tissue repair (M2) macrophages has been 
elucidated, with important consequences of TCA cycle activity and integrity for regulation of 
NO and N-glycosylation signaling respectively
12
.  Whether TCA cycle activity and succinate 
accumulation regulates HIF-1α activity and hypoxic survival in neutrophils is unknown.  
 
Patients with rare germline mutations in genes encoding the TCA cycle enzyme succinate 
dehydrogenase (SDH) allow us to directly question the role of the TCA cycle and 
mitochondrial respiratory chain in neutrophil survival responses.  SDH oxidises succinate to 
fumarate in the TCA cycle, and is a ubiquinone oxidoreductase, also functioning in complex II 
of the respiratory chain
13
.  SDH comprises four subunits (A-D), with inherited mutations of 
each of the subunits linked to the development of PHAEO and PGL following somatic 
inactivation of the wild type allele, and loss of heterozygosity
14-16
.  We questioned whether 
heterozygous germline mutations in SDHB (SDHBx) would reduce SDH activity in the 
peripheral blood neutrophils of these patients, leading to accumulation of intracellular 
succinate, HIF-1α stabilization and a pseudo-hypoxic survival phenotype given the 
importance of the B subunit for SDH catalytic function and its high prevalence within 
PHAEO/PGL patient populations
13,17,18
. 
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To determine whether succinate is implicated in regulating neutrophil survival responses we 
isolated peripheral blood neutrophils from patients with heterozygous germline SDHBx 
mutations in whom an increase in intracellular succinate would be predicted. In total, 20 
individuals were studied with a combination of frame-shift, splice and non-sense mutations 
(Supplementary Table 1). Although all but one patient displayed plasma succinate levels 
within the normal range, a significantly higher plasma succinate level was observed in 
patients with SDHBx (Figure 1a).  To confirm the consequence of SDHB mutations on 
intracellular succinate and measure other TCA cycle and glycolytic intermediaries, peripheral 
blood neutrophils were isolated from 3 individuals with SDHBx and 3 healthy controls and 
relative metabolite abundance determined by gas chromatography-mass spectrometry 
(Figure 1b).  Succinate was significantly more abundant in neutrophils isolated from patients 
with SDHBx than controls.  This was paralleled by increases in lactic acid and citric acid, but 
no changes in other TCA cycle intermediaries (α-ketoglutaric acid, fumaric acid or malic acid).  
Thus neutrophils hetezygous for mutant SDHB gene expression display the predicted 
elevation in intracellular succinate but with no decrease in downstream TCA cycle 
intermediaries. Citric acid levels were increased, which may reflect an increase in biosynthetic 
requirements out-with the TCA cycle.  In keeping with the increased succinate in SDHBx 
neutrophils, a detectable increase in protein succinylation was also observed (Figure 1c).   
 
The consequence of SDHB heterozygosity for constitutive rates of neutrophil apoptosis and 
hypoxic survival responses was determined.  SDHBx neutrophils displayed both reduced 
constitutive apoptosis and enhanced survival in hypoxia, as assessed both by cellular 
morphology (Figure 1d) and Annexin-V positivity (Figure 1e).  Given the previous report of 
succinate-mediated HIF-1α stabilization in BMDMs
11
, and the importance of HIF-1α for 
hypoxic neutrophil survival
6
, we asked whether the reduced apoptosis in SDHBx neutrophils 
was secondary to increased HIF-1α activity.  HIF-1α protein in SDHBx neutrophils was 
elevated in hypoxia (Figure 2a,b), but undetectable in normoxic cells, in which reduced rates 
of apoptosis were observed.  Thus, the phenotype of enhanced neutrophil survival in the 
setting of SDHB heterozygosity occurs independently of HIF-1α protein expression.  In 
keeping with unaltered HIF-1α activity in normoxic SDHBx neutrophils, we saw no alterations 
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either in glucose uptake (Figure 2c,d), in which a hypoxic uplift is observed in healthy control 
cells, or in extracellular acidification rates, an indirect measure of glycolytic activity (Figure 
2e).  Interestingly, we observed that neutrophils isolated from individuals with SDHB 
mutations displayed significantly reduced levels of oxidant stress (Figure 2f), a phenotype 
associated with enhanced neutrophil survival in CGD patients
19
. However, no differences in 
NADP/NADPH redox ratios were detected between patients and controls suggesting the 
SDHB phenotype to be independent of altered NOX2 activity (Figure 2g).  This led us to 
question whether SDH was regulating apoptosis through its role as a mitochondrial 
ubiquinone oxidoreductase. SDHBx neutrophils demonstrated an increased ratio of oxidized 
to reduced NAD
+
 (Figure 2h) and treatment of healthy human neutrophils with the irreversible 
SDH inhibitor 3-nitropropionic acid reduced constitutive neutrophil apoptosis (Figure 2i), thus 
implicating impaired mitochondrial complex II and compensatory changes in the electron 
transport chain in the enhanced survival of SDHB-mutant neutrophils.  
 
These studies utilize a valuable patient group with a specific mutation in SDHB as an 
experimental system in which to delineate the role of the TCA cycle and mitochondrial 
respiratory chain in neutrophil survival responses.  It provides the first description of elevated 
intra-cellular succinate levels in neutrophils isolated from patients with heterozygous 
mutations in SDHB and the first evidence of a dysfunctional TCA cycle in resting state 
peripheral blood neutrophils.  In marked contrast to the role of succinate in facilitating HIF-
1α−dependent inflammatory responses in LPS-stimulated macrophages, we dissociate 
enhanced neutrophil survival from HIF-1α stabilization in the context of germline mutations in 
SDH, linking it instead to a phenotype of impaired mitochondrial complex II function and 
reduced oxidative stress. Taken together, his work identifies key metabolic differences 
between neutrophils and macrophages, and raises further important questions as to the 
metabolic control of neutrophil function and survival.  Future work dissecting the 
consequences of SDHB mutations for neutrophil host-pathogen responses and inflammation 
resolution will be key in this regard. 
 
 
!∀#∃%&∋()(∗+,−%.,/),0.%,.∋(1+2/∗3%−∋14∗4)3%
% 9%
Acknowledgements 
This work was principally supported by a Wellcome Trust Senior Clinical Fellowship awarded 
to SRW (098516), Medical Research Council (MRC) Clinical Training Fellowship awards to 
AART (G0802255) and RSD (MR/K023845/1), and a MRC/ESPRC OPTIMA PhD studentship 
to JW.  The MRC / University of Edinburgh Centre for Inflammation Research is supported by 
an MRC Centre Grant.  PC is supported by Methusalem funding from the Flemish 
Government.   
 
Authorship 
Contribution: R.J, K.M., J.A.W., D.S., A.H., A.A.R.T., R.S.D., T.P., A.L., and P.S. performed 
the research; E.D., and J.N-P., identified and recruited patients; R.J., K.M., J.A.W., B.G., B.K. 
interpreted the data; and P.C., J.N-P., M.K.B.W. and S.R.W. designed the research and wrote 
the manuscript. 
 
Conflict of Interest 
The authors declare no competing financial interests. 
 
The online version of this article contains a data and methods supplement. 
 
References 
1. Levene P, Meyer G. The action of leucocytes on glucose. J Biol Chem. 1912;11:361-
370. 
2. Fossati G, Moulding DA, Spiller DG, Moots RJ, White MR, Edwards SW. The 
mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory 
burst activation, and commitment to apoptosis. Journal of Immunology. 2003;170(4):1964-
1972. 
3. Hannah S, Mecklenburgh K, Rahman I, Bellingan GJ, Greening A, Haslett C, Chilvers 
ER. Hypoxia prolongs neutrophil survival in vitro. FEBS Letters. 1995;372(2-3):233-237. 
!∀#∃%&∋()(∗+,−%.,/),0.%,.∋(1+2/∗3%−∋14∗4)3%
% :%
4. Mecklenburgh KI, Walmsley SR, Cowburn AS, Wiesener M, Reed BJ, Upton PD, 
Deighton J, Greening AP, Chilvers ER. Involvement of a ferroprotein sensor in hypoxia-
mediated inhibition of neutrophil apoptosis. Blood. 2002;100(8):3008-3016. 
5. McGovern NN, Cowburn AS, Porter L, Walmsley SR, Summers C, Thompson AA, 
Anwar S, Willcocks LC, Whyte MK, Condliffe AM, Chilvers ER. Hypoxia selectively inhibits 
respiratory burst activity and killing of Staphylococcus aureus in human neutrophils. Journal 
of Immunology. 2011;186(1):453-463. 
6. Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, Cramer T, 
Sobolewski A, Condliffe AM, Cowburn AS, Johnson N, Chilvers ER. Hypoxia-induced 
neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J ExpMed. 
2005;201(1):105-115. 
7. Walmsley SR, Chilvers ER, Thompson AA, Vaughan K, Marriott HM, Parker LC, 
Shaw G, Parmar S, Schneider M, Sabroe I, Dockrell DH, Milo M, Taylor CT, Johnson RS, 
Pugh CW, Ratcliffe PJ, Maxwell PH, Carmeliet P, Whyte MK. Prolyl hydroxylase 3 (PHD3) is 
essential for hypoxic regulation of neutrophilic inflammation in humans and mice. The Journal 
of clinical investigation. 2011;121(3):1053-1063. 
8. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, 
Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N, Johnson RS. HIF-1alpha is 
essential for myeloid cell-mediated inflammation. Cell. 2003;112(5):645-657. 
9. Takeda N, O'Dea EL, Doedens A, Kim JW, Weidemann A, Stockmann C, Asagiri M, 
Simon MC, Hoffmann A, Johnson RS. Differential activation and antagonistic function of HIF-
{alpha} isoforms in macrophages are essential for NO homeostasis. Genes and 
Development. 2010;24(5):491-501. 
10. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, Hurtado-
Ziola N, Nizet V, Johnson RS. HIF-1alpha expression regulates the bactericidal capacity of 
phagocytes. Journal of Clinical Investigation. 2005;115(7):1806-1815. 
11. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, 
Frezza C, Bernard NJ, Kelly B, Foley NH, Zheng L, Gardet A, Tong Z, Jany SS, Corr SC, 
Haneklaus M, Caffrey BE, Pierce K, Walmsley S, Beasley FC, Cummins E, Nizet V, Whyte M, 
Taylor CT, Lin H, Masters SL, Gottlieb E, Kelly VP, Clish C, Auron PE, Xavier RJ, O'Neill LA. 
!∀#∃%&∋()(∗+,−%.,/),0.%,.∋(1+2/∗3%−∋14∗4)3%
% ;%
Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature. 
2013;496(7444):238-242. 
12. Jha AK, Huang SC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, 
Chmielewski K, Stewart KM, Ashall J, Everts B, Pearce EJ, Driggers EM, Artyomov MN. 
Network integration of parallel metabolic and transcriptional data reveals metabolic modules 
that regulate macrophage polarization. Immunity. 2015;42(3):419-430. 
13. Sun F, Huo X, Zhai Y, Wang A, Xu J, Su D, Bartlam M, Rao Z. Crystal structure of 
mitochondrial respiratory membrane protein complex II. Cell. 2005;121(7):1043-1057. 
14. Baysal BE, Willett-Brozick JE, Lawrence EC, Drovdlic CM, Savul SA, McLeod DR, 
Yee HA, Brackmann DE, Slattery WH, 3rd, Myers EN, Ferrell RE, Rubinstein WS. Prevalence 
of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck 
paragangliomas. Journal of Medical Genetics. 2002;39(3):178-183. 
15. Burnichon N, Briere JJ, Libe R, Vescovo L, Riviere J, Tissier F, Jouanno E, 
Jeunemaitre X, Benit P, Tzagoloff A, Rustin P, Bertherat J, Favier J, Gimenez-Roqueplo AP. 
SDHA is a tumor suppressor gene causing paraganglioma. Human Molecular Genetics. 
2010;19(15):3011-3020. 
16. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van 
der Mey A, Taschner PE, Rubinstein WS, Myers EN, Richard CW, 3rd, Cornelisse CJ, 
Devilee P, Devlin B. Mutations in SDHD, a mitochondrial complex II gene, in hereditary 
paraganglioma. Science. 2000;287(5454):848-851. 
17. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skoldberg F, Husebye ES, 
Eng C, Maher ER. Gene mutations in the succinate dehydrogenase subunit SDHB cause 
susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet. 
2001;69(1):49-54. 
18. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson 
M, Dahia PL, Elston M, Gimm O, Henley D, Herman P, Murday V, Niccoli-Sire P, Pasieka JL, 
Rohmer V, Tucker K, Jeunemaitre X, Marsh DJ, Plouin PF, Robinson BG. Clinical 
presentation and penetrance of pheochromocytoma/paraganglioma syndromes. Journal of 
Clinical Endocrinology and Metabolism. 2006;91(3):827-836. 
!∀#∃%&∋()(∗+,−%.,/),0.%,.∋(1+2/∗3%−∋14∗4)3%
% <%
19. Kasahara Y, Iwai K, Yachie A, Ohta K, Konno A, Seki H, Miyawaki T, Taniguchi N. 
Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-
mediated apoptosis of neutrophils. Blood. 1997;89(5):1748-1753. 
 
 
  
!∀#∃%&∋()(∗+,−%.,/),0.%,.∋(1+2/∗3%−∋14∗4)3%
% =%
Figure Legends 
Figure 1. Heterozygous SDHB neutrophils display a specific metabolic signature and 
enhanced survival. 
(A) Plasma succinate concentrations were determined for 97 controls and 19 patients with 
germline mutations in SDHB.  Filled, half-filled and open circles represent patients without, 
with previous, and with current tumours respectively.  Solid lines represent median values 
and dashed lines upper and lower limits of reference.  (B-E) Human peripheral blood 
neutrophils from healthy controls (HC, filled) and SDHBx patients (open) were studied in 
parallel.  (B) Relative metabolite abundance. Freshly isolated neutrophils were lysed in 
methanol and the liquid phase subjected to gas chromatography-mass spectrometry, and 
relative quantification of 20 key metabolic intermediaries performed.  Data represents mean 
+/- SEM, n=3.  (C) Succinylation. Freshly isolated neutrophil lysates were separated by SDS-
PAGE and membranes probed for succinylated protein expression relative to β-actin control, 
blot representative of n=3.  (D,E) Apoptosis.  Neutrophils were cultured for 20 hours in 
normoxia or hypoxia and apoptosis determined by morphology (D) and flow cytometry 
(Annexin V) (E).  Solid bars represent mean, P values were determined by Mann-Whitney U 
test (A), unpaired t-test (B) or 2-way ANOVA (D,E). 
  
Figure 2. SDHBx neutrophil survival is independent of HIF-1α  expression and linked to 
uncoupling of the mitochondrial electron transport chain.  
Human peripheral blood neutrophils from healthy controls (HC, filled) and SDHB patients 
(open) were studied in parallel.  (A,B) HIF-1α protein expression. Freshly isolated neutrophils 
and neutrophils aged for 4 hours in normoxia (N) or hypoxia (H) were lysed, separated by 
SDS-PAGE, membranes probed for HIF-1α and p38 MAPK expression and densitometry on 
hypoxic samples performed.  Representative blot shown (A) with mean densitometry +/- SEM, 
n=6 (B).  (C,D) Glucose uptake. Neutrophils were pre-incubated in glucose-free PBS in 
normoxia (N) or hypoxia (H) for 1 hour prior to stimulation with 100nM fMLP in the presence 
of 200µM 2-NBDG for 20 mins.  Uptake was determined by flow cytometry (FL1 geometric 
mean fluorescence).  Data represents mean +/- SEM, n=5.  (E) Glycolytic capacity. 
Neutrophils were cultured +/- glucose, 2DG (10mM) or LPS (1mg/ml) for 2 hours prior to 
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stimulation with 100nM fMLP and peak extracellular acidification rates determined by 
Seahorse.  Data represents mean +/- SEM, n=4.  (F) Intra-cellular ROS.  DCF fluorescence 
was quantified following 45 mins neutrophil culture in the presence or absence of fMLP (100 
nM), and fold change in patient neutrophil fluorescence calculated relative to healthy controls.  
(G,H) Electron transport.  Ratios of oxidized to reduced NADP (G) and NAD (H) were 
measured by fluorimetric enzyme cycling assay in freshly isolated and aged neutrophils (6 
hours).  (I) Apoptosis. Neutrophils were cultured for 20 hours in the presence or absence of 
3NP (0-2 mM) and apoptosis determined by morphological appearance, data represents 
mean +/- SEM, n=4. P values were determined by unpaired (B), paired (C,D,I) or one-sample 
(F) t-tests or 2-way ANOVA (G,H). 
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